XBiotech Inc (NASDAQ: XBIT) stock suffered a major decline of -10.9% on 7/19/24. The shares closed at $5.97. This decline was accompanied by normal trading volume. The stock has declined -10.4% during the last week but has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
XBIT is expected to continue to be Value Creation neutral reflecting capital returns that are forecasted to be in line with the cost of capital.
XBiotech has a current Value Trend Rating of C (High Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. XBiotech has a poor Appreciation Score of 25 but a very high Power Rating of 92, with the High Neutral Value Trend Rating the result.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment